openPR Logo
Press release

GMP Cell Banking Services Market to Surpass US$ 1,326.8 Million by 2027

08-10-2020 01:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

GMP Cell Banking Services Market

GMP Cell Banking Services Market

Microbial cell culture or microbiological culture are the cell of bacteria and algae. These cell cultures are used to produce organic chemicals and proteins. Insect cell lines are derived from Drosophila melanogaster, Spodoptera frugiperda, and Trichoplusia ni for study of insect developmental biology, physiology, and microbial pathology and to produce vaccines.

Statistics:

The global GMP cell banking services market is estimated to account for US$ 1,326.8 Mn in terms of value by the end of 2027.

Request Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/3634

Global GMP Cell Banking Services Market: Drivers

Limited in-house storage and testing capabilities are expected to propel growth of the global GMP cell banking services market over the forecast period. Large biopharmaceutical companies have several manufacturing sites that typically produce commercially marketed therapeutics as well as material for clinical development. As a result, the in-house capacity for storage of GMP cell banks are limited.

Global GMP Cell Banking Services Market: Opportunities

Government initiatives to support the growth of the domestic biotechnology industry is expected to offer lucrative growth opportunities for players in the market. For instance, in March 2020, the state government of Telangana, India, announced its plans to increase the market value of biotech and life sciences industry from US$ 50 billion to US$ 100 billion.

Global GMP Cell Banking Services Market: Restraints

Inconsistent demand for services is expected to hamper growth of the global GMP cell banking services market. Considering that outsourcing happens on a molecule-by-molecule basis, cell banking service providers experience fluctuating demand as large biopharmaceutical clients alternate between storage of cell banks in-house and outsourcing to service providers. The decision to outsource also depends on the performance of candidates in clinical trials, which can be quite unpredictable. Hence, service providers have to ensure a consistent source of revenue in these situations.

Key Takeaways:

The Mammalian cell type segment in the global GMP cell banking services market was valued at US$ 286.6 Mn in 2019 and is expected to reach US$ 917.8 Mn by 2027 at a CAGR of 15.7% during the forecast period. Increasing demand for stem cell is expected to propel the growth of the segment during the forecast period.

The Biopharmaceutical Companies segment held dominant position in the global GMP cell banking services market in 2019, accounting for 70.1% share in terms of value during the forecasted period. Increasing funding for R&D in rare diseases is expected to boost growth of the segment during the forecast period.

Market Trends

Major players in the market are focused on conducting training regarding culture media. For instance, in October 2019, Lonza Group Ltd. hosted a free 60-minute webinar addressing current concerns regarding the use of serum in cell culture media.

Major players in the market are also focused on expanding their production capacity. For instance, in March 2019, Goodwin Biotechnology, Inc. purchased the two-acre site where the company is based in order to expand its capacity to meet the needs of its long-term clients.

Regulations

U.S.

ICH guidelines issued by FDA

Various ICH guidelines have been published that are relevant to cGMP recommendations for contract manufacturing arrangements

ICH Q7: Companies evaluate contract facilities to ensure that contractor sites comply with CGMP for specific operations
ICH Q9: Offers a systematic approach to quality risk management as part of an effective quality system
ICH Q10: As part of a pharmaceutical quality system, the pharmaceutical company is ultimately responsible for ensuring that processes are in place to assure the control of outsourced activities and quality of purchased materials
21 CFR 211.22(d)

Requirement of quality unit activities to be in writing
cGMP regulations require that quality unit activities and procedures be in writing, and that these procedures be followed by contract manufacturing organizations. A quality agreement describes the owner’s and the contract facility’s roles and manufacturing activities under cGMP. From a CGMP perspective, manufacturing activities are the most important element in a quality agreement. The most critical pieces are quality and change control.
Global GMP Cell Banking Services Market: Competitive Landscape

Major players operating in the global GMP cell banking services market include, WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.

Global GMP Cell Banking Services Market: Key Developments

November 2019: Lonza Group Ltd. launched eCHO Basal Medium and Feed, a system designed to optimize protein production, in order to expand its cell culture media portfolio

November 2018: Goodwin Biotechnology, Inc. received contract from Radimmune Therapeutics to develop a process and manufacture Radimmune Therapeutics’ lead therapeutic oncology candidate for clinical development

Request Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/3634

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Author:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GMP Cell Banking Services Market to Surpass US$ 1,326.8 Million by 2027 here

News-ID: 2108305 • Views:

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample

All 5 Releases


More Releases for GMP

Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides. As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp. This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008. “ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures. The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,